“With generative AI becoming more capable of producing remarkably convincing radiology reports, there’s a greater risk of fabricated reports being used to falsify medical histories and support fraudulent claims,” the team cautioned.
When working-age adults develop cardiovascular disease, it often ends up eating up a significant amount of their income. Are insurance companies doing enough to help these patients?
The American Association for Thoracic Surgery has announced a new partnership with the Cardiothoracic Surgical Trials Network. The groups plan on working together to address current challenges in cardiothoracic surgery research.
Lyme disease patients treated for “brain fog” may develop compensatory alterations in white matter that show up on MRI and correspond—unexpectedly—with slow but sound cognitive performance.
Pregnant women who felt stressed by healthcare disruptions caused by the COVID-19 pandemic radiated the unease to their developing offspring. The effects were observable on fetal MRI of both brainstem structure and functional activity.
"We expected to see a significant improvement in outcomes for patients with severe or rapidly progressing cardiogenic shock who underwent early ECMO treatment," one specialist said.
Two late-breaking clinical trials presented at the VIVA Foundation’s VIVA22 conference in Las Vegas highlighted the impact drug-coated balloons can make on patient outcomes.
Though it is not yet clear why some COVID patients develop thyroiditis and some do not, researchers maintain that their findings “support the hypothesis of a direct thyroid gland involvement in SARS‐CoV‐2 infection.”
The new study, based on data from nearly 1,400 PAD patients who were treated with Shockwave Medical's IVL technology, was presented at VIVA22 in Las Vegas.
At the annual ASTRO meeting, experts shared that not only did the shortened protocol shave weeks off of the scheduled treatment plan, it also did not come at the expense of increased toxicity.
